Knockdown of BRD4 in T‐ALL cell lines Jurkat and J.gamma1 resulted in a significant decrease in IRF2BP2 expression at both the protein and mRNA levels (Figure 1D,E). The gene discussed is BRD4; the disease is acute lymphoblastic leukemia.